View in EDS

Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.

Saved in:
Bibliographic Details
Title: Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.
Authors: Carroll, Alistair, Bayes, Adam, Montebello, Mark, Brett, Jonathan, Arunogiri, Shalini, Saunders, John B, Loo, Colleen K
Source: Australian & New Zealand Journal of Psychiatry. Oct2024, Vol. 58 Issue 10, p831-838. 8p.
Subjects: Drug addiction risk factors, Substance abuse, Ketamine, Medical prescriptions, Affective disorders, Drug delivery systems, Antidepressants, Drug abuse, Mental depression, Drug resistance, Drug tolerance
Geographic Terms: New Zealand, Australia
Abstract: Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict use in those with drug dependence. There is substantial variation in definitions of drug dependence used in each jurisdiction, and between the legal and clinical definitions, with the latter specified in the current International Classification of Diseases, Eleventh Revision and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This paper reviews the literature assessing the risk of ketamine misuse and dependence in patients with a history of illicit drug use, abuse or dependence and presents recommendations for psychiatrists who prescribe ketamine in such patients with treatment-resistant depression. [ABSTRACT FROM AUTHOR]
Copyright of Australian & New Zealand Journal of Psychiatry is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 179974147
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Carroll%2C+Alistair%22">Carroll, Alistair</searchLink><br /><searchLink fieldCode="AR" term="%22Bayes%2C+Adam%22">Bayes, Adam</searchLink><br /><searchLink fieldCode="AR" term="%22Montebello%2C+Mark%22">Montebello, Mark</searchLink><br /><searchLink fieldCode="AR" term="%22Brett%2C+Jonathan%22">Brett, Jonathan</searchLink><br /><searchLink fieldCode="AR" term="%22Arunogiri%2C+Shalini%22">Arunogiri, Shalini</searchLink><br /><searchLink fieldCode="AR" term="%22Saunders%2C+John+B%22">Saunders, John B</searchLink><br /><searchLink fieldCode="AR" term="%22Loo%2C+Colleen+K%22">Loo, Colleen K</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Australian+%26+New+Zealand+Journal+of+Psychiatry%22">Australian & New Zealand Journal of Psychiatry</searchLink>. Oct2024, Vol. 58 Issue 10, p831-838. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Drug+addiction+risk+factors%22">Drug addiction risk factors</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+abuse%22">Substance abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Ketamine%22">Ketamine</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+prescriptions%22">Medical prescriptions</searchLink><br /><searchLink fieldCode="DE" term="%22Affective+disorders%22">Affective disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+delivery+systems%22">Drug delivery systems</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+abuse%22">Drug abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+resistance%22">Drug resistance</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+tolerance%22">Drug tolerance</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22New+Zealand%22">New Zealand</searchLink><br /><searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict use in those with drug dependence. There is substantial variation in definitions of drug dependence used in each jurisdiction, and between the legal and clinical definitions, with the latter specified in the current International Classification of Diseases, Eleventh Revision and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This paper reviews the literature assessing the risk of ketamine misuse and dependence in patients with a history of illicit drug use, abuse or dependence and presents recommendations for psychiatrists who prescribe ketamine in such patients with treatment-resistant depression. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Australian & New Zealand Journal of Psychiatry is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=179974147
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/00048674241242315
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 831
    Subjects:
      – SubjectFull: Drug addiction risk factors
        Type: general
      – SubjectFull: Substance abuse
        Type: general
      – SubjectFull: Ketamine
        Type: general
      – SubjectFull: Medical prescriptions
        Type: general
      – SubjectFull: Affective disorders
        Type: general
      – SubjectFull: Drug delivery systems
        Type: general
      – SubjectFull: Antidepressants
        Type: general
      – SubjectFull: Drug abuse
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Drug resistance
        Type: general
      – SubjectFull: Drug tolerance
        Type: general
      – SubjectFull: New Zealand
        Type: general
      – SubjectFull: Australia
        Type: general
    Titles:
      – TitleFull: Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Carroll, Alistair
      – PersonEntity:
          Name:
            NameFull: Bayes, Adam
      – PersonEntity:
          Name:
            NameFull: Montebello, Mark
      – PersonEntity:
          Name:
            NameFull: Brett, Jonathan
      – PersonEntity:
          Name:
            NameFull: Arunogiri, Shalini
      – PersonEntity:
          Name:
            NameFull: Saunders, John B
      – PersonEntity:
          Name:
            NameFull: Loo, Colleen K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 00048674
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Australian & New Zealand Journal of Psychiatry
              Type: main
ResultId 1